ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2015, Vol. 24 ›› Issue (2): 101-106.

• 论文 •    下一篇

维持性血液透析患者血清成纤维细胞生长因子23与血管钙化和左心室肥厚的关系

  

  • 出版日期:2015-04-28 发布日期:2015-04-29

Association of serum FGF 23 with the cardiovascular calcification and left ventricular hypertrophy in maintenance hemodialysis patients

  • Online:2015-04-28 Published:2015-04-29

摘要:

摘要 目的:观察182例维持性血液透析(MHD)患者的成纤维细胞生长因子23(FGF23)水平、影响因素及与血管钙化和左心室肥厚(LVH)的关系。方法:检测血清全段FGF23水平,血清钙磷、全段甲状旁腺素(iPTH),血清25羟维生素D,及常规实验室指标,记录调节钙磷代谢的用药情况,螺旋CT检测冠脉钙化评分(CACS),腹部侧位平片检测腹主动脉钙化评分(AACs),心脏超声检测心脏指标。结果:FGF23水平显著升高,用四分位法将患者分为四组:组1(77.7-1260.8),组2(1290.9-5934.6),组3(6969.8-27219.7),组4(27487.3,-234869.2)(pg/ml),随着组间FGF23水平的升高,患者年龄更大,踝臂指数更低,血红蛋白更低,血磷更高(p<0.05),FGF23与血磷的相关系数为0.435(P=0.01)。同时,血清25羟维生素D水平呈下降趋势,lgiPTH、活性维生素D的处方率、左心室质量指数(LVMI)、LVH的患病率均呈上升趋势,但无统计学差异。除了AACS≥5的患者随着FGF23升高腹主动脉钙化的患病率增加外(P=0.048),其余各组血管钙化患病率及严重程度有升高趋势,但无统计学差异。结论:循环FGF23水平在维持性血液透析患者中明显升高,其水平与血磷升高相关。高FGF23水平的患者腹主动脉钙化(AACS≥5)的患病率增加,未发现FGF23与冠状动脉钙化、LVH患病率的相关性。

关键词: 维持性血液透析, 成纤维细胞生长因子23, 冠状动脉钙化, 腹主动脉钙化, 左心室质量指数, 左心室肥厚

Abstract:

Abstract Objective: To determine the serum levels of fibroblast growth factor (FGF23) and to explore the relationships of FGF23 with vascular calcification and left ventricular hypertrophy (LVH) in patients with maintenance hemodialysis (MHD). Methodology: A cross-sectional observation on one hundred eighty two patients with MHD was performed in this study. The serum intact FGF23, serum calcium and phosphorus, intact parathyroid hormone (iPTH), 25 hydroxy vitamin D, and routine laboratory examination index were examined.  The agents for regulating the metabolism of calcium and phosphorus were recorded. Patients undergone spiral CT to get coronary calcification score (CACS), abdominal lateral plain film examine to get abdominal aortic calcification score (AACS), and cardiac ultrasound examine to get cardiac indexs. Results: The levels of serum FGF23 were significantly increased in our patients with MHD. According to the levels of FGF23, the patients were divided into four groups. With the increasing levels of FGF23, the patients were older, ankle brachial index was lower, hemoglobin was lower, and serum phosphorus was higher (p<0.05). The correlation coefficient of serum FGF23 and serum phosphorus was 0.435(p=0.001). The levels of serum 25 (OH) D showed a decreasing trend, while lgiPTH, prescription of vitamin D, Left ventricular mass index(LVMI), the prevalence of left ventricular hypertrophy (LVH) showed an increasing trend, but the difference was not statistically significant. In addition to the patients with AACS≥5, the prevalence of abdominal aortic calcification was increased with FGF23 elevation (P=0.048), the prevalence and severity of vascular calcification of the other groups had a rising trend, but the difference was not statistically significant. Conclusion: The levels of serum FGF23 were increased significantly in patients with, which was related with the increasing levels of serum phosphorus. No relationships of serum FGF23 levels with coronary artery calcification and prevalence of LVH was found, except the patients with abdominal aorta calcification(AACS≥5).
 

Key words: maintenance hemodialysis, fibroblast growth factor 23, coronary artery calcification, abdominal aortic calcification, left ventricular hypertrophy